Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy

Blood

Volumn 87, Issue 5, 1996, Pages 1951-1956

  Blankenberg, Francis G ^a   Storrs, Richard W ^a   Naumovski, Louie ^a   Goralski, Thomas ^a   Spielman, Daniel ^a  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL DEATH; CELL STRAIN 3T3; CELL STRAIN HL 60; CONTROLLED STUDY; DAUDI CELL; HELA CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; T CELL LEUKEMIA;

EID: 0030028330     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1951.1951     Document Type: Article

References (28)

1. Jensen KE, Jensen M, Grundtvig P, Thomsen C, Karle H, Henriksen O: Localized in vivo proton spectroscopy of the bone marrow in patients with leukemia. Magn Reson Imaging 8:779, 1990
2. Ballon D, Jakubowski A, Gabrilove J, Graham MC, Zakowski M, Sheridan C, Koutcher JA: In vivo measurements of bone marrow cellularity using volume-localized proton NMR spectroscopy. Magn Reson Med 19:85, 1991
3. Schick F, Bongers H, Jung WI, Skalej M, Lutz O, Claussen CD: Volume-selective proton MRS in vertebral bodies. Magn Reson Med 26:207, 1992
4. Gerard EL, Ferry JA, Amrein PC, Harmon DC, McKinstry RC, Hoppel BE, Rosen BR: Compositional changes in vertebral bone marrow during treatment for acute leukemia: Assessment with quantitative chemical shift imaging. Radiology 183:39, 1992
5. 1H spectroscopy. Ann Hematol 66:3, 1993
6. Mulkern RV, Meng J, Oshio K, Guttmann CRG, Jaramillo D: Bone marrow characterization in the lumbar spine with inner volume spectroscopic CPMG imaging studies. J Magn Reson Imaging 4:585, 1994
7. Steller H: Mechanisms and genes of cellular suicide. Science 267:1445, 1995
8. Nagata S, Golstein P: The fas death factor. Science 267:1449, 1995
9. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
10. Bansal N, Houle AG, Melnykovych G: Comparison of dexamethasone and lovastatin (mevinolin) as growth inhibitors in cultures of T cell derived human acute leukemia lines (CEM). Leuk Res 13:875, 1989
11. Bulva CJ, Printen J, Melynkovych G, Cutts L, Barisas BG, Roess DA: Corticosteroid effects on lipid lateral diffusion in CEM-C1 and CEM-C7 acute lymphoblastic leukemia cells. Biochim Biophys Acta 1094:134, 1991
12. Schlegel RA, Stevens M, Lumley-Sapanski K, Williamson P: Altered lipid packing identifies apoptotic thymocytes. Immunol Lett 36:283, 1993
13. Schimke RT: Meeting report, fifth annual pezcoller symposium: Apoptosis. Cancer Res 54:302, 1994
14. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM: Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148:2207, 1992
15. Koopman G, Reutelingsperger CPM, Kuijten GAM, Keehnen RJM, Pals ST, van Oers MHJ: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84:1415, 1994
16. Homburg CHE, de Haas M, von dem Borne AEG, Verhoeven AJ, Reutelingsperger CPM, Roos D: Human neutrophils lose their surface FcγRIII and acquire annexin V binding sites during apoptosis in vitro. Blood 85:532, 1995
17. Mountford CE, Grossman G, Reid G, Fox RM: Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. Cancer Res 42:2270, 1982
18. Mountford CE, Wright LC, Holmes KT, Mackinnon WB, Gregory P, Fox RM: High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells. Science 226:1415, 1984
19. May GL, Wright LC, Holmes KT, Williams PG, Smith ICP, Wright PE, Fox RM, Mountford CE: Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride. J Biochem 261:3048, 1986
20. Mountford CE, Tattersall MHN: Proton magnetic resonance spectroscopy and tumor detection. Cancer Surv 6:285, 1987
21. Asselin BL, Ryan D, Frantz CN, Bernal SD, Leavitt P, Sallan SE, Cohen HJ: In vitro and in vivo killing of acute lymphoblastic leukemia cells by L-asparaginase. Cancer Res 49:4363, 1989
22. Niemeyer CM, Gelber RD, Tarbell NJ, Donnelly M, Clavell LA, Blattner SR, Donahue K, Cohen HJ, Sallan SE: Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 Update). Blood 78:2514, 1991
23. Naumovski L, Cleary ML: Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83:2261, 1994
24. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE, Wyllie AH: Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim Biophys Acta 1133:275, 1992
25. 31P NMR characterization of cellular metabolism during dexamethasone induced apoptosis in human leukemic cell lines. J Cell Physiol 158:180, 1994
26. Delikatny EJ, Russell P, Hunter JC, Hancock R, Atkinson KH, van Haaften-Day C, Mountford CE: Proton MR and Human Cervical Neoplasia: Ex vivo spectroscopy allows distinction of invasive carcinoma of the cervix from carcinoma in situ and other preinvasive lesions. Radiology 188:791, 1993
27. Russell P, Lean CL, Delbridge L, May GL, Dowd S, Mountford CE: Proton magnetic resonance and human thyroid neoplasia I: Discrimination between benign and malignant neoplasms. Am J Med 96:383, 1994
28. Bizzi A, Movsas B, Tedeschi G, Phillips CL, Okuniefs P, Alger JR, Di Chiro G: Response of non-Hodgkin lymphoma to radiation therapy: Early and long-term assessment with H-1 MR spectroscopic imaging. Radiology 194:271, 1995